跳至主要内容
临床试验/NCT07683429
NCT07683429已完成不适用

Comparative Effectiveness of Local Corticosteroid Injection and Open Surgical Release for Pain Outcomes in De Quervain Tenosynovitis: A Single-Centre Study

Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年3月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Pain intensity - Visual Analog Scale (VAS)

研究概览

简要总结

This quasi-experimental study compared pain outcomes following local corticosteroid injection (CSI) versus open surgical release in 100 patients with clinically confirmed De Quervain tenosynovitis unresponsive to conservative management. Patients were allocated to treatment based on clinician judgment and patient preference. Pain was assessed using the Visual Analog Scale (VAS) at baseline, one month, and six months post-intervention. The study was conducted at a single tertiary care centre in Rawalpindi, Pakistan between March 2023 and April 2025.

详细描述

De Quervain tenosynovitis is a stenosing tendinopathy of the first dorsal extensor compartment of the wrist, causing radial-sided wrist pain. One hundred patients were enrolled and allocated to either corticosteroid injection (CSI; n=49) or open surgical release (n=51). The CSI protocol consisted of triamcinolone acetonide (40mg/mL, 1mL) combined with 1% lidocaine (1mL) injected into the first dorsal compartment under aseptic conditions. Surgical release involved longitudinal decompression of the fibro-osseous sheath overlying the APL and EPB tendons. The primary outcome was VAS pain score at baseline, one month, and six months. Statistical analysis included independent t-tests and linear mixed-effects modeling.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

VAS assessments at follow-up were performed by a trained assessor blinded to treatment allocation.

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of De Quervain tenosynovitis confirmed by positive Finkelstein test
  • Age 18-70 years
  • Pain sufficiently severe to impair activities of daily living
  • Failure to respond to at least 4 weeks of conservative management

排除标准

  • Concurrent inflammatory arthropathy (rheumatoid arthritis or gout)
  • History of prior wrist injury
  • Previous surgical or injection treatment for De Quervain tenosynovitis
  • Coexisting upper limb pathology (rotator cuff pathology, epicondylitis, or carpal tunnel syndrome)

结局指标

主要结局

Pain intensity - Visual Analog Scale (VAS)

时间窗: Time Frame: Baseline, 1 month, and 6 months post-intervention

Pain scored on a 0-10 VAS scale where 0 = no pain and 10 = worst imaginable pain, assessed by a blinded assessor

次要结局

  • Adverse events(Throughout 6-month follow-up period)

研究者

发起方
Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Osama Ijaz

Post-graduate resident Trauma & Orthopedics

Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi

研究点 (1)

Loading locations...

相似试验